Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease

BACKGROUND: Empagliflozin exerted positive cardiorenal effects in the EMPA-KIDNEY trial; this study reports active trial plus post-trial data. METHODS: In this trial, patients with an estimated glomerular filtration rate 20-<45; or 45-<90mL/min/1.73m(2) and urinary albumin-to-creatinine ratio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:N Engl J Med
Main Authors: Herrington, William G., Staplin, Natalie, Agrawal, Nikita, Wanner, Christoph, Green, Jennifer B., Hauske, Sibylle J., Emberson, Jonathan R., Preiss, David, Judge, Parminder, Zhu, Doreen, Dayanandan, Rejive, Arimoto, Ryoki, Mayne, Kaitlin J., Ng, Sarah Y.A., Sammons, Emily, Hill, Michael, Stevens, Will, Wallendszus, Karl, Brenner, Susanne, Cheung, Alfred K., Liu, Zhi-Hong, Li, Jing, Hooi, Lai Seong, Liu, Wen, Kadowaki, Takashi, Nangaku, Masaomi, Levin, Adeera, Cherney, David Z.I, Maggioni, Aldo P., Pontremoli, Roberto, Deo, Rajat, Goto, Shinya, Rossello, Xavier, Tuttle, Katherine R., Steubl, Dominik, Massey, Dan, Brueckmann, Martina, Landray, Martin J., Baigent, Colin, Haynes, Richard
Formato: Artigo
Idioma:Inglês
Publicado em: 2024
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7616743/
https://ncbi.nlm.nih.gov/pubmed/39453837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa2409183
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados